Seeking Alpha

MAPP
  MAP Pharmaceuticals, Inc. - NASDAQ

11/23/2014, 5:47 AM ET
MAPP is defunct since March 4, 2013. acquired by a private company
Company Description
MAP Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs in neurology. The Company is developing LEVADEX®, an orally inhaled investigational drug for the potential acute treatment of migraine. The U.S. Food and... More